Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/20/2024
Novo Nordisk gets FDA OK for new indication for Wegovy
Wegovy is now indicated to reduce the risk of serious heart problems in overweight or obese adults. - 3/19/2024
Kenvue affirms commitment to healthy lives mission
Kenvue plans to share its progress toward goals and commitments in an inaugural Healthy Lives Mission Report in June 2024. - 3/19/2024
Camber debuts generic Gralise
Camber’s generic Gralise tablets are indicated for the management of Postherpetic Neuralgia. - 3/19/2024
Lupin appoints Rakesh Bhardwaj as chief information officer
Bhardwaj will lead Lupin’s global information technology function and spearhead the company’s digital transformation. - 3/19/2024
What will consumers’ shopping behavior look like for the 2024 holidays?
Consumers are gravitating toward online retailers that make personalized offers with deals and discounts, bolstered by free shipping and easy access to customer reviews. - 3/19/2024
Unilever’s Ice Cream division to become standalone business
Following the separation of the ice cream division, including Ben & Jerry's, Unilever will operate four business groups across beauty and wellbeing; personal care; home care and nutrition. - 3/19/2024
Jeff Needham receives CHPA’s Ivan D. Combe Lifetime Achievement Award
The Ivan D. Combe Lifetime Achievement Award is the highest honor bestowed by the U.S. consumer healthcare industry. - 3/19/2024
Dollar General makes personal care donations to address period poverty
Seven Dollar General distribution centers and their employees across the nation donated more than 36,000 feminine hygiene products in 2023. - 3/18/2024
Avenacy launches 2 new generics
Avenacy is offering two new products, Fosaprepitant for Injection, which is the generic of Emend, and Fulvestrant Injection, which is the generic of Foslodex. - 3/18/2024
AAM commends Kentucky for enacting bill increasing patient biosimilar access
On March 14, Governor Andy Beshear signed Kentucky House Bill 220 into law, which allows health plans to encourage greater adoption of lower-cost biosimilar medicines.
